L-carnosine and zinc in gastric protection
- Authors
- Choi H.S.; Kim E.S.; Keum B.; Chun H.J.; Sung M.-K.
- Issue Date
- Aug-2015
- Publisher
- Royal Society of Chemistry
- Citation
- Food and Nutritional Components in Focus, v.2015-January, no.8, pp 548 - 565
- Pages
- 18
- Journal Title
- Food and Nutritional Components in Focus
- Volume
- 2015-January
- Number
- 8
- Start Page
- 548
- End Page
- 565
- URI
- https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/10475
- DOI
- 10.1039/9781782622611-00548
- ISSN
- 2045-1695
- Abstract
- The incidence of gastric mucosal injury has been increasing rapidly because nonsteroidal anti-inflammatory drugs (NSAIDs) and antithrombotic agents are being increasingly prescribed, especially to elderly patients. Several approaches for gastric mucosa defense have been adopted for the prevention and cure of gastropathy, including gastric ulcers. Zinc l-carnosine is used for the treatment of gastric mucosal damage disease. Zinc l-carnosine (or polaprezinc) is a chelated compound that consists of l-carnosine and zinc. Zinc l-carnosine protects the mucosa against aggressive injury factors and has been found to prevent gastric mucosal injury in diverse experimental models through anti-inflammatory action, antioxidant action, growth factors, and cytoprotective factors such heat-shock proteins. Zinc l-carnosine is effective in treating Helicobacter pylori infection, NSAID-induced gastric injury, ethanol-induced gastropathy, and acetic acid-gastric damage. In conclusion, zinc l-carnosine is a valuable mucosal protective agent with multiple targets that can be used in gastric mucosal damage healing. © 2015 The Royal Society of Chemistry.
- Files in This Item
-
Go to Link
- Appears in
Collections - 생활과학대학 > 식품영양학과 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.